Pharmaceutical Development Program Strategy & Pre-Clinical Clinical Development Regulatory Market Access Commercialization Quality & Compliance Advisory, Transformation & Design The Source
Drug Substance Development (API)
Drug Product Development​
Manufacturing Operations
Manufacturing Compliance
Development Strategy​
Program Evaluation
Non-Clinical Study Execution
Non-Clinical Regulatory Submissions
Non-Clinical Compliance
Clinical Development Strategy
Clinical Operations & Study Management​
Medical Writing & Regulatory Submissions
Clinical Compliance​
Pre-Approval
Authoring, Publishing & Submissions
Post-Approval
Functional Outsourcing
Special Projects
Strategy Development
Achieving Market Access
Artwork & Labeling​
Distribution
Product Release Process
Pre-Approval Inspections & Vendor Audits
Good Laboratory Practice (GLP)
Good Clinical Practice (GCP)
Good Manufacturing Practice (GMP)
Inspection Readiness
Organizational Assessment, Strategy & Design
Implementation, Excellence & Transformation
M&A Regulatory Due Diligence & Integration
Digital Technology Advisory
Case Studies
Regulatory Affairs FAQs Our Brochure
Career Opportunities Contract Opportunities
Select your language
  • Go back
  • Drug Substance Development (API)
  • Drug Product Development​
  • Manufacturing Operations
  • Manufacturing Compliance
  • Go back
  • Development Strategy​
  • Program Evaluation
  • Non-Clinical Study Execution
  • Non-Clinical Regulatory Submissions
  • Non-Clinical Compliance
  • Go back
  • Clinical Development Strategy
  • Clinical Operations & Study Management​
  • Medical Writing & Regulatory Submissions
  • Clinical Compliance​
  • Go back
  • Pre-Approval
  • Authoring, Publishing & Submissions
  • Post-Approval
  • Functional Outsourcing
  • Special Projects
  • Go back
  • Strategy Development
  • Achieving Market Access
  • Go back
  • Artwork & Labeling​
  • Distribution
  • Product Release Process
  • Pre-Approval Inspections & Vendor Audits
  • Go back
  • Good Laboratory Practice (GLP)
  • Good Clinical Practice (GCP)
  • Good Manufacturing Practice (GMP)
  • Inspection Readiness
  • Go back
  • Organizational Assessment, Strategy & Design
  • Implementation, Excellence & Transformation
  • M&A Regulatory Due Diligence & Integration
  • Digital Technology Advisory
    • Contact Us

    Talk to an expert. Get in touch.

    © 2024 G&L Scientific

    Select your language

    Contract Opportunities

    GCP Audits (Remote)

    Contract: August 2026

    Apply Now

    Exclusive to The Source - register/apply now

    G&L is supporting 2 remote GCP audits of a client's CRO vendor and requires an APAC-based auditor.

    The Role

    The audits will focus on CRO execution, oversight, compliance, and operational effectiveness, using targeted sampling to confirm appropriate implementation.

    The CRO is based in Australia and requires an auditor in the APAC region who can commit to conducting the audit between 9am-5pm Melbourne/Sydney time.

    Requirements

    Audit Dates:

    Audit 1: 24th-26th August 2026

    Audit 2: 27th-28th August 2026

    Audits to be conducted between 9am-5pm Melbourne/Sydney time.

    Audit Details:

    4 hours audit preparation

    24 hours audit activities

    12 hours audit report finalisation

    40 hours total per audit

    How to Apply

    This contract opportunity is exclusive to The Source.

    To apply or request further information, please register or sign in by clicking the button below.

    Apply Now